Procept Biorobotics Corporation (PRCT) - News Archive

PROCEPT BioRobotics: A Surgical Robotics Player Gathers Momentum with Major Stock OfferingOn October 29, 2024, PROCEPT BioRobotics Corporation, based in San Jose, California and listed on NASDAQ under the ticker PRCT, a...

Procept BioRobotics Capitalizes on Strategic Expansion Amidst Breakthroughs in Urological TreatmentSan Jose, Calif. In a strategic move set to bolster its market presence, PROCEPT BioRobotics Corporation (NASDAQ: PRCT),...

In a significant advancement for prostate cancer treatment, PROCEPT BioRobotics Corporation has received U.S. Food and Drug Administration (FDA) approval to initiate a pivotal randomized clinical study assessing the saf...

In a significant advancement for urological care, PROCEPT BioRobotics recently announced the FDA clearance of its HYDROS Robotic System. This system represents a cutting-edge, artificial intelligence-powered platform sp...

SAN JOSE, Calif., June 17, 2024 In a significant stride towards revolutionizing urological care, PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a pioneering surgical robotics company, proudly announced today that the A...

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic HyperplasiaData from the Icahn School of Medicine at Mount Sinai and Potomac Urology presented at the 2024 A...